πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,022 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10131653

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10125145

5-HT3 receptor antagonists

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10112956

Heterocyclic compounds having cholesterol 24-hydroxylase activity

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10106556

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10100018

Amide derivatives as lysophosphatidic acid receptor antagonists

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10098866

Pharmaceutical preparation containing copolyvidone

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10093629

Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inh

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10087229

Peptide compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10087150

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10085986

Pyrimidinone compounds and their use

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10081624

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10077266

Substituted pyrido[3,4-b]pyrazines as GPR6 modulators

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10059713

3-substituted 2-amino-indole derivatives

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10053468

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10053456

Cyclopropanamine compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10023544

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10017487

Fused heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10017508

Nitrogenated heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10017734

Method for producing dopaminergic neurons

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10011588

1,2-substituted cyclopentanes as orexin receptor antagonists

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10005780

Production method of imidazole derivatives

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10004691

Orally disintegrable tablet

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10000468

Pyrazines as modulators of GPR6

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10000488

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted